Cureus | The Benefits Outweigh the Risks of Treating Hypercholesterolemia: The Statin Dilemma | Article
How to Tackle Statin Induced New Onset Diabetes (Type-2) - CME INDIA
Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model | Scientific Reports
A review of the molecular mechanisms leading to diabetic and statin induced neuropathies: exploring the similarities between the two and the role of coenzyme Q in its treatment
Statin treatment and new-onset diabetes: A review of proposed mechanisms - ScienceDirect
Statins Are Associated With Increased Insulin Resistance and Secretion | Arteriosclerosis, Thrombosis, and Vascular Biology
Statin-Related New-Onset Diabetes Appears Driven by Increased Insulin Resistance: Are There Clinical Implications? | Arteriosclerosis, Thrombosis, and Vascular Biology
Possible mechanisms of statin induced diabetes | Download Scientific Diagram
Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brown adipose tissue | SpringerLink
Frontiers | Statins and New-Onset Diabetes Mellitus: LDL Receptor May Provide a Key Link
Hypothetical paradigm for statin-induced impairment of glucose... | Download Scientific Diagram
Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL. | Semantic Scholar
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials - The Lancet
Statin treatment and new-onset diabetes: A review of proposed mechanisms - ScienceDirect
Statins and Risk of New-Onset Diabetes Mellitus | Circulation
Statin use and risk of developing diabetes: results from the Diabetes Prevention Program | BMJ Open Diabetes Research & Care
Risk of incident diabetes among patients treated with statins: population based study | The BMJ
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials - The Lancet
PCSK9 Inhibitor: Safe Alternative to Fill the Treatment Gap in Statin-Limited Conditions?
Possible mechanisms of statin induced diabetes | Download Scientific Diagram
Statins and diabetes risk
Frontiers | Pharmacogenetics of Statin-Induced Myotoxicity
